|
|
|
|
|
Izabela M. Domanska, Ramona Figat, Aldona Zalewska, Krystyna Ciesla, Sebastian Kowalczyk, Karolina Kedra and Marcin Sobczak
The effect of ionizing radiation (?-rays and electron beam) on anticancer drug delivery systems (DDSs) properties was evaluated concerning potential sterilization. For this purpose, paclitaxel (PTX)-loaded nanoparticles were obtained using a biodegradabl...
ver más
|
|
|
|
|
|
|
|
|
|
|
Bárbara Costa, Rita Matos, Irina Amorim, Fátima Gärtner and Nuno Vale
The breast cancer therapies available are insufficient, especially since first-line treatments, such as paclitaxel, result in drug resistance and their toxicity often limits their concentration. Strategies like drug repurposing are beneficial, and novel ...
ver más
|
|
|
|
|
|
|
|
|
|
|
Katyayani Tatiparti, Mohd Ahmar Rauf, Samaresh Sau and Arun K. Iyer
Triple-negative breast cancer (TNBC) is amongst the most challenging tumor subtypes because it presents itself without the estrogen, progesterone, and HER2 receptors. Hence, assessing new markers is an essential requirement for enhancing its targeted tre...
ver más
|
|
|
|
|
|
|
|
|
|
|
Marco Aurélio Cremasco, Linda Nien-Hwa Wang
Pág. 33 - 40
Paclitaxel, as known Taxol®, is an important agent in cancer treatment, founded in mixture with many structural analogs, or taxanes, present in natural source or plant tissue culture broth. The adsorption techniques are used in the purification of placli...
ver más
|
|
|
|
|
|